1. Home
  2. ATAI vs RDWR Comparison

ATAI vs RDWR Comparison

Compare ATAI & RDWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • RDWR
  • Stock Information
  • Founded
  • ATAI 2018
  • RDWR 1996
  • Country
  • ATAI Netherlands
  • RDWR Israel
  • Employees
  • ATAI N/A
  • RDWR N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • RDWR EDP Services
  • Sector
  • ATAI Health Care
  • RDWR Technology
  • Exchange
  • ATAI Nasdaq
  • RDWR Nasdaq
  • Market Cap
  • ATAI 1.1B
  • RDWR 1.2B
  • IPO Year
  • ATAI 2021
  • RDWR 1999
  • Fundamental
  • Price
  • ATAI $5.88
  • RDWR $25.67
  • Analyst Decision
  • ATAI Strong Buy
  • RDWR Hold
  • Analyst Count
  • ATAI 5
  • RDWR 3
  • Target Price
  • ATAI $14.00
  • RDWR $32.50
  • AVG Volume (30 Days)
  • ATAI 7.1M
  • RDWR 116.5K
  • Earning Date
  • ATAI 11-14-2025
  • RDWR 10-29-2025
  • Dividend Yield
  • ATAI N/A
  • RDWR N/A
  • EPS Growth
  • ATAI N/A
  • RDWR N/A
  • EPS
  • ATAI N/A
  • RDWR 0.38
  • Revenue
  • ATAI $2,309,000.00
  • RDWR $294,636,000.00
  • Revenue This Year
  • ATAI $736.04
  • RDWR $11.14
  • Revenue Next Year
  • ATAI N/A
  • RDWR $7.27
  • P/E Ratio
  • ATAI N/A
  • RDWR $66.81
  • Revenue Growth
  • ATAI 510.85
  • RDWR 10.40
  • 52 Week Low
  • ATAI $1.04
  • RDWR $18.46
  • 52 Week High
  • ATAI $6.75
  • RDWR $31.57
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 52.01
  • RDWR 46.68
  • Support Level
  • ATAI $5.50
  • RDWR $25.14
  • Resistance Level
  • ATAI $6.23
  • RDWR $27.48
  • Average True Range (ATR)
  • ATAI 0.46
  • RDWR 0.87
  • MACD
  • ATAI -0.06
  • RDWR -0.05
  • Stochastic Oscillator
  • ATAI 26.71
  • RDWR 30.41

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About RDWR Radware Ltd.

Radware Ltd provides cyber security and application delivery solutions. The company provides solutions for cloud, on-premises, and software-defined data centers (SDDC). The solutions of the company secure the digital experience by providing infrastructure, application, and network protection and availability services to enterprises globally. The business segments of the company are Radware's Core Business and The Hawks' Business. The company derives maximum revenue from Radware's Core Business. It generates the majority of its revenue from the United States.

Share on Social Networks: